Chea Chanbora, Lee Duck-Yeon, Kato Jiro, Ishiwata-Endo Hiroko, Moss Joel
bioRxiv. 2023 Feb 7:2023.02.07.527501. doi: 10.1101/2023.02.07.527501.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for a global pandemic that resulted in more than 6-million deaths worldwide. The virus encodes several non-structural proteins (Nsps) that contain elements capable of disrupting cellular processes. Among these Nsp proteins, Nsp3 contains macrodomains, e.g., Mac1, Mac2, Mac3, with potential effects on host cells. Mac1 has been shown to increase SARS-CoV-2 virulence and disrupt ADP-ribosylation pathways in mammalian cells. ADP-ribosylation results from the transfer of the ADP-ribose moiety of NAD to various acceptors, e.g., proteins, DNA, RNA, contributing on a cell's biological processes. ADP-ribosylation is the mechanism of action of bacterial toxins, e.g., Pseudomonas toxins, diphtheria toxin that disrupt protein biosynthetic and signaling pathways. On the other hand, some viral macrodomains cleavage ADP-ribose-acceptor bond, generating free ADP-ribose. By this reaction, the macrodomain-containing proteins interfere ADP-ribose homeostasis in host cells. Here, we examined potential hydrolytic activities of SARS-CoV-2 Mac1, 2, and 3 on substrates containing ADP-ribose. Mac1 cleaved α-NAD , but not β-NAD , consistent with stereospecificity at the C-1" bond. In contrast to ARH1 and ARH3, Mac1 did not require Mg for optimal activity. Mac1 also hydrolyzed -acetyl-ADP-ribose and ADP-ribose-1"-phosphat, but not Mac2 and Mac3. However, Mac1 did not cleave α-ADP-ribose-(arginine) and ADP-ribose-(serine)-histone H3 peptide, suggesting that Mac1 hydrolyzes ADP-ribose attached to O- and N-linked functional groups, with specificity at the catalytic site in the ADP-ribose moiety. We conclude that SARS-CoV-2 Mac1 may exert anti-viral activity by reversing host-mediated ADP-ribosylation. New insights on Nsp3 activities may shed light on potential SARS-CoV-2 therapeutic targets.
SARS-CoV-2, the virus responsible for COVID-19, encodes 3 macrodomain-containing proteins, e.g., Mac1, Mac2, Mac3, within non-structural proteins 3 (Nsp3). Mac1 was shown previously to hydrolyze ADP-ribose-phosphate. Inactivation of Mac1 reduced viral proliferation. Here we report that Mac1, but not Mac2 and Mac3, has multiple activities, i.e., Mac1 hydrolyzed. α-NAD and -acetyl-ADP-ribose. However, Mac1 did not hydrolyze β-NAD , ADP-ribose-serine on a histone 3 peptide (aa1-21), and ADP-ribose-arginine, exhibiting substrate selectivity. These data suggest that Mac1 may have multi-function as a α-NAD consumer for viral replication and a disruptor of host-mediated ADP-ribosylation pathways. Understanding Mac1's mechanisms of action is important to provide possible therapeutic targets for COVID-19.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发了一场全球大流行,在全球导致了600多万人死亡。该病毒编码几种非结构蛋白(Nsps),这些蛋白含有能够破坏细胞过程的元件。在这些Nsp蛋白中,Nsp3含有多个宏结构域,如Mac1、Mac2、Mac3,对宿主细胞可能有影响。Mac1已被证明会增加SARS-CoV-2的毒力,并破坏哺乳动物细胞中的ADP-核糖基化途径。ADP-核糖基化是由NAD的ADP-核糖部分转移到各种受体(如蛋白质、DNA、RNA)上产生的,对细胞的生物学过程有影响。ADP-核糖基化是细菌毒素(如假单胞菌毒素、白喉毒素)的作用机制,这些毒素会破坏蛋白质生物合成和信号通路。另一方面,一些病毒宏结构域会切割ADP-核糖-受体键,产生游离的ADP-核糖。通过这种反应,含有宏结构域的蛋白质会干扰宿主细胞中的ADP-核糖稳态。在这里,我们研究了SARS-CoV-2的Mac1、2和3对含ADP-核糖底物的潜在水解活性。Mac1能切割α-NAD,但不能切割β-NAD,这与C-1”键处的立体特异性一致。与ARH1和ARH3不同,Mac1的最佳活性不需要Mg。Mac1还能水解O-乙酰-ADP-核糖和ADP-核糖-1”-磷酸,但Mac2和Mac3不能。然而,Mac1不能切割α-ADP-核糖-(精氨酸)和ADP-核糖-(丝氨酸)-组蛋白H3肽,这表明Mac1水解与O-和N-连接官能团相连的ADP-核糖,在ADP-核糖部分的催化位点具有特异性。我们得出结论,SARS-CoV-2的Mac1可能通过逆转宿主介导的ADP-核糖基化发挥抗病毒活性。对Nsp3活性的新见解可能有助于揭示潜在的SARS-CoV-2治疗靶点。
导致COVID-19的病毒SARS-CoV-2在非结构蛋白3(Nsp3)中编码3种含宏结构域蛋白,即Mac1、Mac2、Mac3。先前已表明Mac1能水解ADP-核糖-磷酸。Mac1失活会降低病毒增殖。在这里我们报告,Mac1具有多种活性,而Mac2和Mac3没有,即Mac1能水解α-NAD和O-乙酰-ADP-核糖。然而,Mac1不能水解β-NAD、组蛋白3肽(aa1-21)上的ADP-核糖-丝氨酸和ADP-核糖-精氨酸,表现出底物选择性。这些数据表明,Mac1可能具有多种功能,既是病毒复制的α-NAD消耗者,又是宿主介导的ADP-核糖基化途径的破坏者。了解Mac1的作用机制对于为COVID-19提供可能的治疗靶点很重要。